These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21366826)

  • 41. Topical prophylaxis of conjunctivitis induced by high-dose cytosine arabinoside.
    Matteucci P; Carlo-Stella C; Di Nicola M; Magni M; Guidetti A; Marchesi M; Gianni AM
    Haematologica; 2006 Feb; 91(2):255-7. PubMed ID: 16461314
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Comparison of the efficiency of various externally used corticosteroids].
    Horácek J; Semrádová V
    Z Hautkr; 1974 Jul; 49(13):555-8. PubMed ID: 4423320
    [No Abstract]   [Full Text] [Related]  

  • 43. Betamethasone dipropionate (0.05%) plus salicylic acid (3%) ointment versus dexamethasone trimethyl acetate (1%) and salicylic acid 4% ointments in chronic dermatoses.
    Chattopadhyay SP; Arora PN; Anand S; Sharma SD
    Indian J Dermatol; 1987 Apr; 32(2):41-4. PubMed ID: 3453353
    [No Abstract]   [Full Text] [Related]  

  • 44. In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices.
    Hickey T; Kreutzer D; Burgess DJ; Moussy F
    J Biomed Mater Res; 2002 Aug; 61(2):180-7. PubMed ID: 12007197
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of a novel bioerodible dexamethasone implant for uveitis and postoperative cataract inflammation.
    Chennamaneni SR; Mamalis C; Archer B; Oakey Z; Ambati BK
    J Control Release; 2013 Apr; 167(1):53-9. PubMed ID: 23321274
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effect of topical dexamethasone treatment on antigen-presenting cells in murine corneas].
    Müller A; Zhang EP; Hoffmann F
    Ophthalmologe; 2003 Apr; 100(4):310-3. PubMed ID: 12682764
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polymeric delivery systems for dexamethasone.
    Urbańska J; Karewicz A; Nowakowska M
    Life Sci; 2014 Feb; 96(1-2):1-6. PubMed ID: 24373835
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Accelerated ocular hypertensive response after application of corticosteroid ointment to a child's eyelid.
    Chua JK; Fan DS; Leung AT; Lam DS
    Mayo Clin Proc; 2000 May; 75(5):539. PubMed ID: 10807086
    [No Abstract]   [Full Text] [Related]  

  • 49. The effect of recombinant human hyaluronidase on dexamethasone penetration into the posterior segment of the eye after sub-Tenon's injection.
    Kozak I; Kayikcioglu OR; Cheng L; Falkenstein I; Silva GA; Yu DX; Freeman WR
    J Ocul Pharmacol Ther; 2006 Oct; 22(5):362-9. PubMed ID: 17076631
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pharmacokinetics of site-specific delivery of dexamethasone-dextran prodrug in rat gastrointestinal tract].
    Zhou SY; Mei QB; Zhou J; Liu L; Li C; Zhao DH
    Yao Xue Xue Bao; 2001 May; 36(5):325-8. PubMed ID: 12584851
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of serum dexamethasone concentrations in cats after oral or transdermal administration using pluronic lecithin organogel (PLO): a pilot study.
    Willis-Goulet HS; Schmidt BA; Nicklin CF; Marsella R; Kunkle GA; Tebbett IR
    Vet Dermatol; 2003 Apr; 14(2):83-9. PubMed ID: 12662265
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The pharmacokinetics of dexamethasone in the thoroughbred racehorse.
    Cunningham FE; Rogers S; Fischer JH; Jensen RC
    J Vet Pharmacol Ther; 1996 Feb; 19(1):68-71. PubMed ID: 8992029
    [No Abstract]   [Full Text] [Related]  

  • 53. Biomarkers to guide the use of corticosteroids in community-acquired pneumonia: a wish rather than a tangible concept.
    Salluh JI; Povoa P
    J Infect; 2013 Mar; 66(3):290. PubMed ID: 23068451
    [No Abstract]   [Full Text] [Related]  

  • 54. Optimized release of dexamethasone and gentamicin from a soluble ocular insert for the treatment of external ophthalmic infections.
    Baeyens V; Kaltsatos V; Boisramé B; Varesio E; Veuthey JL; Fathi M; Balant LP; Gex-Fabry M; Gurny R
    J Control Release; 1998 Mar; 52(1-2):215-20. PubMed ID: 9685951
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Erythrocyte-mediated delivery of dexamethasone in patients with chronic obstructive pulmonary disease.
    Rossi L; Serafini S; Cenerini L; Picardi F; Bigi L; Panzani I; Magnani M
    Biotechnol Appl Biochem; 2001 Apr; 33(2):85-9. PubMed ID: 11277860
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Pharmacokinetic study of ophthalmic ointments of hydrocortisone acetate in combination with sodium sulfapyridazine].
    Atiia MA; Ivanova LA
    Farmatsiia; 1978; 27(5):28-30. PubMed ID: 700179
    [No Abstract]   [Full Text] [Related]  

  • 57. Prednisolone and dexamethasone are systemically absorbed after topical application of ophthalmic suspensions in healthy dogs.
    Ewald MM; Rankin AJ; Meekins JM; Magnin G; KuKanich B
    Am J Vet Res; 2022 Jan; 83(4):339-348. PubMed ID: 35038305
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Study on the enzyme dependant colon targeting prodrug--dexamethasone succinate dextran and its tablets].
    Pang YN; Zhang ZR; Pang QJ; Li TL
    Yao Xue Xue Bao; 2001 Aug; 36(8):625-30. PubMed ID: 12579944
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Radiosterilization of an ophthalmic ointment containing hydrocortisone-acetate. 3. Physical and chemical analysis of the ophthalmic ointment].
    Hangay G
    Acta Pharm Hung; 1970 May; 40(3):116-23. PubMed ID: 5430262
    [No Abstract]   [Full Text] [Related]  

  • 60. Phonophoresis and the absorption of dexamethasone in the presence of an occlusive dressing.
    Saliba S; Mistry DJ; Perrin DH; Gieck J; Weltman A
    J Athl Train; 2007; 42(3):349-54. PubMed ID: 18059989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.